Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $3.85 USD
Change Today +0.12 / 3.22%
Volume 2.1M
GERN On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

David L. Greenwood

Former Director of Geron Bio-Med Limited, Geron Corporation
AgeTotal Calculated CompensationThis person is connected to 12 board members in 2 different organizations across 3 different industries.

See Board Relationships
62$922,841

Background*

Mr. David L. Greenwood served as the President of Geron Corporation from February 9, 2011 to January 5, 2012, and the Chief Financial Officer from August 1995 to January 5, 2012. Mr. Greenwood served as the Chief Executive Officer at Geron Corporation since February 2011. Mr. Greenwood served as Secretary and Treasurer at Geron Corporation from August 1995 to February 2011 and its Executive Vice President from January 2004 to February 2011. He served as an Interim Chief ...

Read Full Background

Corporate Headquarters*

149 Commonwealth Drive
Menlo Park, California 94025

United States

Phone: 650-473-7700
Fax: 650-473-7750

Board Members Memberships*

2010-Present
Chairman and Chairman of Audit Committee
2011-2011
Former Director of Geron Bio-Med Limited
2014-Present
Director, Chairman of Audit Committee, Member of Compensation Committee and Member of Nominating Committee

Education*

MBA
Harvard Business School
BA
Pacific Lutheran University Inc

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$465,000
Total Calculated Compensation$922,841
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GERN:US $3.85 USD +0.12

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Actavis plc
--
Heather Bresch Chief Executive Officer, Executive Director and Member of Science & Technology Committee
Mylan N.V.
$1.1M
Shigetaka Komori Chairman, Chief Executive Officer, Chairman of Compliance Committee and Chairman of Risk Management Committee
FUJIFILM Holdings Corporation
¥201.0M
Roger L. Hawley Chief Executive Officer, Interim Chief Commercial Officer and Director
Zogenix, Inc.
$449.3K
Vikram Lamba Chief Executive Officer, President and Director
Zosano Pharma Corporation
$412.0K
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GERON CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.